Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $7,750 |
Sells | 26 | $267,502 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Mar 2024 16:41 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 19 Mar 2024 | Sale | 5,268 | 2.0855 | 10,986 | D |
21 Mar 2024 16:40 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 19 Mar 2024 | Sale | 20,223 | 2.0855 | 42,175 | D |
21 Mar 2024 16:38 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | SVP, Finance and Accounting | 19 Mar 2024 | Sale | 2,971 | 2.0855 | 6,196 | D |
21 Mar 2024 16:37 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 19 Mar 2024 | Sale | 12,795 | 2.0855 | 26,684 | D |
21 Mar 2024 16:36 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 19 Mar 2024 | Sale | 6,562 | 2.0855 | 13,685 | D |
22 Dec 2023 16:16 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 20 Dec 2023 | Sale | 13,551 | 1.3807 | 18,710 | D |
22 Dec 2023 16:14 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 20 Dec 2023 | Sale | 4,077 | 1.3805 | 5,628 | D |
22 Dec 2023 16:12 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 20 Dec 2023 | Sale | 4,077 | 1.3805 | 5,628 | D |
22 Dec 2023 16:11 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 20 Dec 2023 | Sale | 4,077 | 1.3807 | 5,629 | D |
22 Dec 2023 16:10 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | SVP, Finance and Accounting | 20 Dec 2023 | Sale | 1,990 | 1.3806 | 2,747 | D |
22 Sep 2023 19:16 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 22 Sep 2023 | Sale | 4,119 | 1.3003 | 5,356 | D |
22 Sep 2023 19:15 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 22 Sep 2023 | Sale | 4,119 | 1.3003 | 5,356 | D |
22 Sep 2023 19:13 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 22 Sep 2023 | Sale | 14,601 | 1.3004 | 18,987 | D |
22 Sep 2023 19:12 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 22 Sep 2023 | Sale | 5,486 | 1.3006 | 7,135 | D |
31 Mar 2023 19:56 | CTMX | CytomX Therapeutics Inc | JONES ELAINE V | Director | 29 Mar 2023 | Purchase | 5,000 | 1.55 | 7,750 | D |
20 Mar 2023 18:43 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | SVP, Finance and Accounting | 16 Mar 2023 | Sale | 516 | 1.9793 | 1,021 | D |
20 Mar 2023 18:43 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 16 Mar 2023 | Sale | 7,121 | 1.8805 | 13,391 | D |
20 Mar 2023 18:43 | CTMX | CytomX Therapeutics Inc | CAMPOY CARLOS | Chief Financial Officer | 16 Mar 2023 | Sale | 1,748 | 1.9791 | 3,459 | D |
20 Mar 2023 18:43 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 16 Mar 2023 | Sale | 2,037 | 1.979 | 4,031 | D |
20 Mar 2023 18:43 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Financial Officer | 16 Mar 2023 | Sale | 1,477 | 1.9792 | 2,923 | D |
20 Mar 2023 18:43 | CTMX | CytomX Therapeutics Inc | PETERSON AMY C. | EVP, Chief Development Officer | 16 Mar 2023 | Sale | 4,257 | 1.979 | 8,425 | D |
21 Jul 2022 16:11 | CTMX | CytomX Therapeutics Inc | PETERSON AMY C. | EVP, Chief Development Officer | 20 Jul 2022 | Sale | 7,463 | 1.422 | 10,612 | D |
21 Jul 2022 16:11 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 20 Jul 2022 | Sale | 4,206 | 1.4222 | 5,982 | D |
21 Jul 2022 16:10 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | President and CEO | 20 Jul 2022 | Sale | 14,911 | 1.4222 | 21,206 | D |
21 Jul 2022 16:10 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 20 Jul 2022 | Sale | 5,602 | 1.4223 | 7,968 | D |
21 Jul 2022 16:09 | CTMX | CytomX Therapeutics Inc | HANNAH ALISON L. | Chief Medical Officer | 20 Jul 2022 | Sale | 5,602 | 1.4219 | 7,965 | D |
21 Jul 2022 16:08 | CTMX | CytomX Therapeutics Inc | CAMPOY CARLOS | Chief Financial Officer | 20 Jul 2022 | Sale | 3,949 | 1.4224 | 5,617 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)